EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients

Youngwoo Jang, Byung Jin Kim, Yong Whi Jeong, Dae Ryong Kang, Kwang Kon Koh, Børge G Nordestgaard, Seung Hwan Han

Journal of Lipid Research · 2026-05 · 67 (5) · 101024

DOI: 10.1016/j.jlr.2026.101024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2026-05. Verfasst von Youngwoo Jang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Gachon University Gil Medical Center, Incheon, South Korea; Gachon University, College of Medicine, Incheon, South Korea. Hauptthemen laut MEDLINE: Fenofibrate, Triglycerides, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipoproteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gil Medical Center, Gachon University, Gachon University, College of Medicine, Drexel University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FenofibrateTriglyceridesHydroxymethylglutaryl-CoA Reductase InhibitorsLipoproteinsCholesterolAtherosclerosisHumansFemaleMaleMiddle AgedRisk FactorsAgedHypolipidemic Agents

Stichwörter der Autor:innen

cholesterollipoproteinsmyocardial infarctionstatinstriglycerides

Substanzen

FenofibrateTriglyceridesHydroxymethylglutaryl-CoA Reductase InhibitorsLipoproteinsCholesterollipoprotein cholesterolHypolipidemic Agents

Autor:innen und Institutionen

  • Department of Cardiology, Gachon University Gil Medical Center, Incheon, South Korea; Gachon University, College of Medicine, Incheon, South Korea.
  • Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Seoul, South Korea.
  • Department of Medical Informatics and Biostatistics, Graduate School, Yonsei University, Seoul, South Korea.
  • Department of Precision Medicine, Wonju College of Medicine, Yonsei University, Wonju, South Korea.
  • K-Heart Clinic & Lab, Incheon, South Korea.
  • Department of Clinical Biochemistry, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen,…

Förderung

  • Gil Medical Center, Gachon University
  • Gachon University
  • College of Medicine, Drexel University

Zitieren

APA

Jang, Y., Kim, B. J., Jeong, Y. W., Kang, D. R., Koh, K. K., Nordestgaard, B. G., & Han, S. H. (2026). Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients. Journal of Lipid Research, 67(5), 101024. https://doi.org/10.1016/j.jlr.2026.101024

Vancouver

Jang Y, Kim BJ, Jeong YW, Kang DR, Koh KK, Nordestgaard BG, et al. Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients. Journal of Lipid Research. 2026;67(5):101024. doi:10.1016/j.jlr.2026.101024

BibTeX
@article{Jang2026,
  author = {Jang, Youngwoo and Kim, Byung Jin and Jeong, Yong Whi and Kang, Dae Ryong and Koh, Kwang Kon and Nordestgaard, Børge G and Han, Seung Hwan},
  title = {Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients},
  journal = {Journal of Lipid Research},
  year = {2026},
  volume = {67},
  number = {5},
  pages = {101024},
  doi = {10.1016/j.jlr.2026.101024}
}
Kostenlos starten →